Introduction
This essay presents a case study drawn from practice as a nurse practitioner undertaking the V300 non-medical prescribing qualification in a UK GP surgery. The practitioner runs regular minor illness and injury clinics, managing patients with common presentations such as upper respiratory tract infections and minor musculoskeletal injuries. The case examines one independent prescribing episode and one supplementary prescribing episode, providing a critical analysis focused on independent prescribing decision-making within the legal, ethical and clinical frameworks that govern V300 practice. The discussion draws on the standards set by the Nursing and Midwifery Council and considers patient safety, accountability and evidence-based practice.
Case Context and Patient Presentation
The patient, a 34-year-old woman, presented to a minor illness clinic with a three-day history of dysuria, urinary frequency and mild suprapubic discomfort. She had no fever, no flank pain and no previous urinary tract infections within the past year. Her medical history included well-controlled asthma and no known drug allergies. As part of routine practice in the GP surgery, the nurse practitioner conducted a focused history and examination, excluding red-flag features that would require general practitioner referral. Urinalysis showed nitrites and leucocytes, supporting a working diagnosis of uncomplicated lower urinary tract infection.
The Independent Prescribing Episode
Under the V300 programme, independent prescribing allows the nurse practitioner to assess, diagnose and prescribe without requiring a prior patient-specific clinical management plan written by an independent prescriber. In this episode, the practitioner selected a three-day course of nitrofurantoin 100 mg modified-release capsules twice daily, in line with local antimicrobial guidelines for empirical treatment of uncomplicated cystitis. Decision-making incorporated current resistance patterns, patient contraindications and the requirement to issue a prescription only when clinically necessary. The process highlighted the prescriber’s accountability for the entire episode, including documentation of the rationale, safety-netting advice and arrangements for follow-up should symptoms persist. Critical reflection revealed that while independent prescribing offers timely access to treatment, it demands robust diagnostic reasoning to avoid unnecessary antibiotic use, thereby addressing antimicrobial stewardship priorities emphasised in primary care.
The Supplementary Prescribing Episode
Later in the same clinic session, the practitioner reviewed a separate patient with an acute exacerbation of asthma whose condition had been previously managed under a supplementary prescribing agreement with the general practitioner. A clinical management plan had previously been agreed, specifying parameters for dose adjustment of inhaled corticosteroids and rescue medication. The nurse practitioner assessed symptom control, peak flow readings and inhaler technique before adjusting the dose of beclometasone dipropionate within the agreed limits. This episode demonstrated the collaborative nature of supplementary prescribing, where the nurse works within a defined framework rather than exercising full independent judgement. The contrast between the two episodes underlined that supplementary prescribing can provide structured support for complex chronic conditions yet may limit flexibility when presentations fall outside the plan.
Critical Analysis of Independent Prescribing
The independent prescribing episode invites closer scrutiny because it places full diagnostic and therapeutic responsibility on the nurse practitioner. Legal authority derives from the Human Medicines Regulations 2012, which permit appropriately qualified nurses to prescribe from the full British National Formulary. However, this autonomy requires ongoing competence in history-taking, differential diagnosis and risk assessment. In the present case, the decision to prescribe an antibiotic was supported by national guidance recommending empirical treatment when typical symptoms are present. Nevertheless, the practitioner remained aware that over-reliance on urinalysis without culture in low-risk patients can contribute to overtreatment. Ethical considerations included obtaining informed consent, explaining potential side-effects such as nausea or pulmonary reactions with nitrofurantoin, and providing clear advice about when to re-consult. The episode therefore illustrates the tension between patient-centred care, which values prompt symptom relief, and population-level responsibilities to conserve antibiotic efficacy.
Implications for Practice and Professional Development
Comparison of the two episodes suggests that independent prescribing is most appropriate for acute, straightforward conditions commonly encountered in minor illness clinics, while supplementary prescribing remains valuable for chronic disease management where continuity with the medical team is required. The practitioner’s developing competence under the V300 programme benefits from structured reflection on each consultation, supported by the Nursing and Midwifery Council’s requirement for continuing professional development in prescribing. In primary care settings, where demand for same-day access is high, the ability to prescribe independently can improve service efficiency, provided governance arrangements include regular audit and peer review.
Conclusion
This case study has examined an independent prescribing episode for an uncomplicated urinary tract infection and a supplementary episode for asthma management within a GP surgery minor illness clinic. The analysis demonstrates that independent prescribing confers significant clinical autonomy yet demands rigorous application of diagnostic skills, evidence-based guidelines and professional accountability. Supplementary prescribing offers an alternative framework that promotes collaboration but may constrain responsiveness. For nurse practitioners completing the V300 qualification, developing confidence in both modalities supports safe, effective and patient-responsive prescribing in UK primary care.
References
- Nursing and Midwifery Council (2019) Standards for prescribing programmes. London: Nursing and Midwifery Council.
- Nursing and Midwifery Council (2018) Standards of proficiency for nurse and midwife prescribers. London: Nursing and Midwifery Council.
- National Institute for Health and Care Excellence (2023) Urinary tract infection (lower): antimicrobial prescribing. NG109. Manchester: NICE.
- National Institute for Health and Care Excellence (2022) Asthma: diagnosis, monitoring and chronic asthma management. NG80. Manchester: NICE.
- Royal Pharmaceutical Society (2021) A competency framework for all prescribers. London: Royal Pharmaceutical Society.
- UK Government (2012) The Human Medicines Regulations 2012. London: The Stationery Office.
